Acute liver injury secondary to hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection
- PMID: 33490632
- PMCID: PMC7812516
- DOI: 10.1002/jgh3.12439
Acute liver injury secondary to hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection
Abstract
We present a 23-year-old man with hemophagocytic lymphohistiocytosis (HLH) triggered by Epstein-Bar virus (EBV) infection. This patient presented with persistent fever and acute liver injury 6 weeks after having an infectious mononucleosis associated with EBV infection. He had hypofibrinogenemia, hyperferritinemia, increased soluble interleukin-2 receptor, elevated prothrombin time, and pancytopenia. Bone marrow examination for evaluation of pancytopenia revealed that macrophages had phagocytosed mature erythrocytes. Based on these findings, we suspected an HLH triggered by EBV infection (EBV-HLH). To distinguish from HLH triggered by malignant lymphomas accompanying EBV infection, we performed a percutaneous liver biopsy, which revealed that atypical T-lymphocytes had infiltrated the liver tissues. The T-lymphocytes were positive for EBV-encoded RNA in situ hybridization, and no distinct monoclonal T-cell receptor chain gene rearrangement was detected. These findings indicated EBV hepatitis and, accordingly, malignant lymphoma was ruled out. We finally made a diagnosis of EBV-HLH. The patient was treated with corticosteroid and etoposide, according to HLH-2004 guideline recommendations, and the patient's symptoms and laboratory values improved. After that, he experienced no recurrence. Prompt recognition and initiation of treatment remains the key to the survival of patients with EBV-HLH, and the liver biopsy was helpful in making the diagnosis.
Keywords: hepatic inflammation; viral hepatitis; virology.
© 2020 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Figures

Similar articles
-
Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.Transplant Proc. 2020 Jun;52(5):1566-1569. doi: 10.1016/j.transproceed.2020.02.047. Epub 2020 May 8. Transplant Proc. 2020. PMID: 32389490
-
A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.BMC Pediatr. 2016 Oct 28;16(1):172. doi: 10.1186/s12887-016-0718-3. BMC Pediatr. 2016. PMID: 27793118 Free PMC article.
-
Double Trouble: A Primary Epstein-Barr Virus Infection Causing Cholestatic Hepatitis and Hemophagocytic Lymphohistiocytosis.Cureus. 2022 Nov 2;14(11):e31014. doi: 10.7759/cureus.31014. eCollection 2022 Nov. Cureus. 2022. PMID: 36475200 Free PMC article.
-
Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.J Med Case Rep. 2016 Dec 20;10(1):365. doi: 10.1186/s13256-016-1143-9. J Med Case Rep. 2016. PMID: 27998299 Free PMC article. Review.
-
Acute liver failure caused by hemophagocytic lymphohistiocytosis in adults: A case report and review of the literature.Medicine (Baltimore). 2016 Nov;95(47):e5431. doi: 10.1097/MD.0000000000005431. Medicine (Baltimore). 2016. PMID: 27893685 Free PMC article. Review.
References
-
- Ramos‐Casals M, Brito‐Zerón P, López‐Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014; 383: 1503–16. - PubMed
-
- Henter JI, Horne A, Arico M et al HLH‐2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer. 2007; 48: 124–31. - PubMed
-
- Lai W, Wang Y, Wang J, Wu L, Jin Z, Wang Z. Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis in adults and adolescents – a life‐threatening disease: analysis of 133 cases from a single center. Hematology. 2018; 23: 810–16. - PubMed
Publication types
LinkOut - more resources
Full Text Sources